Publications & Works

Publication Network
Journal articles indexed in SCI, SSCI, and AHCI 12

1. Rapamycin and Niacin combination induces apoptosis and cell cycle arrest through autophagy activation on acute myeloid leukemia cells

Subay L. B., Gencer Akçok E. B., Akçok İ.
Molecular Biology Reports , vol.52, no.1, 2025 (SCI-Expanded) identifier identifier

2. Discovery of New Candidates Targeting the SH2 Domains of Spleen Tyrosine Kinase (Syk) Through In Silico Studies

Şansaçar M., Sarı C., Yücel M. S., Gencer Akçok E. B., Akçok İ.
ChemistrySelect , vol.10, no.22, 2025 (SCI-Expanded) identifier

3. Tomatidine, a Steroidal Alkaloid, Synergizes with Cisplatin to Inhibit Cell Viability and Induce Cell Death Selectively on FLT3-ITD+ Acute Myeloid Leukemia Cells

Ayvaz H. B., Yenigül M., Gencer Akçok E. B.
Cell Biochemistry and Biophysics , vol.82, no.3, pp.2889-2900, 2024 (SCI-Expanded) Sustainable Development identifier identifier

4. Inhibition of PI3K-AKT-mTOR pathway and modulation of histone deacetylase enzymes reduce the growth of acute myeloid leukemia cells

Şansaçar M., Sağır H., GENCER AKÇOK E. B.
Medical Oncology , vol.41, no.1, 2024 (SCI-Expanded) identifier identifier

5. Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells

Yenigül M., GENCER AKÇOK E. B.
ACS Omega , vol.8, no.24, pp.21755-21768, 2023 (SCI-Expanded) identifier identifier

6. Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells

Yenigul M., AKÇOK İ., GENCER AKÇOK E. B.
MOLECULAR BIOLOGY REPORTS , vol.49, no.8, pp.7521-7530, 2022 (SCI-Expanded) Sustainable Development identifier identifier identifier

7. Investigation of the Antitumor Effect of Targeting PI3K-AKT-mTOR Pathway and Histone Deacetylase Enzymes on Acute Myeloid Leukemia Cells

ŞANSAÇAR M., Sagir H., GENCER AKÇOK E. B.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, 2021 (SCI-Expanded) identifier

8. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains

Sha F., Gencer E. B., Georgeon S., Koide A., Yasui N., Koide S., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , vol.110, no.37, pp.14924-14929, 2013 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

9. Mechanisms of resistance to BCR-ABL and other kinase inhibitors

Lamontanara A. J., Gencer E. B., Kuzyk O., Hantschel O.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS , vol.1834, no.7, pp.1449-1459, 2013 (SCI-Expanded) identifier identifier identifier

10. Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance

Camgoz A., Gencer E. B., Ural A. U., Baran Y.
LEUKEMIA & LYMPHOMA , vol.54, no.6, pp.1279-1287, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

11. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes

Gencer E. B., URAL A. U., AVCU F., Baran Y.
ANNALS OF HEMATOLOGY , vol.90, no.11, pp.1265-1275, 2011 (SCI-Expanded) Creative Commons License identifier identifier identifier

12. Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloidleukemia cells

Camgoz A., Gencer E. B., Ural A. U., AVCU F., Baran Y.
LEUKEMIA & LYMPHOMA , vol.52, no.8, pp.1574-1584, 2011 (SCI-Expanded) Creative Commons License identifier identifier identifier
Articles Published in Other Journals 3

1. Targeting HDAC enzymes by SAHA enhances the cytotoxic effects of cisplatin on acute myeloid leukemia cells

Şansaçar M., Pekin Ö., Gencer Akçok E. B.
Journal of Experimental and Clinical Medicine (Turkey) , vol.41, no.3, pp.524-529, 2024 (Scopus) identifier

2. Measurement of Autophagic Activity in Cancer Cells with Flow Cytometric Analysis Using Cyto-ID Staining.

Şansaçar M., Gencer Akçok E. B.
Methods in molecular biology (Clifton, N.J.) , 2024 (Scopus) identifier

3. The therapeutic potential of targeting HDAC6 with Tubastatin A in TFK-1 and EGI-1 cholangiocarcinoma cells

YENİGÜL M., GENCER AKCOK E. B.
Cumhuriyet Science Journal , vol.42, no.4, pp.775-780, 2021 (Peer-Reviewed Journal) Sustainable Development identifier
Metrics

Publication

18

Publication (WoS)

7

Publication (Scopus)

13

Citation (WoS)

132

H-Index (WoS)

5

Citation (Scopus)

236

H-Index (Scopus)

6

Project

4

Thesis Advisory

2
UN Sustainable Development Goals